MSJSX
Global Endurance Portfolio
MORGAN STANLEY INSTITUTIONAL FUND INC
Expense ratio1
0.95%
Net assets2
$15.51M
Holdings2
36
Category
US Equity
2025 return3
24.72%

Investment objective & strategy

As of April 30, 2025 · prospectus

Objective. The Global Endurance Portfolio (the Fund) seeks long-term capital appreciation.

Strategy. Under normal market conditions, the Adviser seeks to achieve the Funds investment objective by investing primarily in equity securities of established and emerging companies located throughout the world, with capitalizations within the range of companies included in the MSCI All Country World Index. The Adviser emphasizes a bottom-up stock selection process, seeking attractive investments on an individual company basis. In selecting securities for investment, the Adviser seeks to invest in companies with strong name recognition and sustainable competitive advantages. The Adviser typically favors companies with rising returns on invested capital, above-average business visibility, strong free cash flow generation and an attractive risk/reward. The Adviser typically focuses a significant portion of the Funds investments in a limited number of issuers, which … Under normal market conditions, the Adviser seeks to achieve the Funds investment objective by investing primarily in equity securities of established and emerging companies located throughout the world, with capitalizations within the range of companies included in the MSCI All Country World Index. The Adviser emphasizes a bottom-up stock selection process, seeking attractive investments on an individual company basis. In selecting securities for investment, the Adviser seeks to invest in companies with strong name recognition and sustainable competitive advantages. The Adviser typically favors companies with rising returns on invested capital, above-average business visibility, strong free cash flow generation and an attractive risk/reward. The Adviser typically focuses a significant portion of the Funds investments in a limited number of issuers, which may be in the same industry, sector or geographic region. The Fund will make long-term investments in companies globally that the Adviser believes have the most durable long-term competitive advantages. The Fund may also invest in more moderate growth companies, companies with lower earnings volatility and/or companies with some cyclicality in their end markets. The Fund may invest in foreign securities, which may include emerging market securities. Under normal market conditions, the Fund typically invests at least 40% of its total assets in the securities of issuers located outside of the United States, unless the Adviser determines, in its sole discretion, that conditions are not favorable. If the Adviser determines that conditions are not favorable, the Fund may invest under 40% of its total assets in the securities of issuers located outside the United States, provided that the Fund will not invest less than 30% of its total assets in such securities except for temporary defensive purposes. In addition, under normal market conditions, the Fund invests in the securities of issuers from at least three different countries, which may include the United States. In addition to common stocks, the Fund may invest in other types of equity securities , including exchange-traded funds (ETFs) (including those which may be managed by the Adviser or its affiliates) .

Top holdings

As of March 31, 2026 · N-PORT
SecurityTickerValue% of fund
ROIVANT SCIENCES LTD $1.36M 8.75%
VICTORIA PLC $1.23M 7.90%
QXO INC $833.66K 5.37%
TELEFLEX INC $797.80K 5.14%
IMMUNOVANT INC $724.46K 4.67%
CALUMET INC $723.64K 4.67%
ARBUTUS BIOPHARMA CORP $666.40K 4.30%
APPIAN CORP CL A $650.44K 4.19%
FLOOR & DECOR-A $561.95K 3.62%
ROYALTY PHARMA PLC $494.23K 3.19%
View all holdings →

Allocation by sector

As of March 31, 2026 · N-PORT
View portfolio breakdown →

Portfolio moves

Dec 31, 2025 → Mar 31, 2026
Opened
17
Exited
5
Increased
1
Decreased
16
Unchanged
2

How many positions this fund opened, exited, grew, trimmed, or left unchanged between its two most recent N-PORT snapshots — net changes between point-in-time reports, not a trade log.

View portfolio moves →

Similar funds

Funds whose portfolios most overlap this one, by weight
FundOverlapNet exp.
Discovery Portfolio · MACGX, MPEGX, MSKLX, MMCGX, MSMFX 22% 0.63%
Discovery Portfolio · MMGTX, MMGPX 22% 0.95%
Inception Portfolio · MSSGX, MSSMX, MSSLX, MFLLX, MSCOX 22% 0.93%
View all similar funds →

Advisers

As of December 31, 2025 · N-CEN
FirmRole
Morgan Stanley Investment Management Inc. Adviser

Footnotes

  1. Expense ratio as of April 30, 2025, from the fund's prospectus.
  2. Net assets and holdings count as of March 31, 2026, from the fund's N-PORT filing.
  3. Total return for calendar year 2025, before tax and after fund expenses. Computed by compounding the twelve monthly total returns the fund reported in its SEC N-PORT filings for 2025 (the latest prospectus does not yet chart this year).

Machine-readable: JSON · Markdown. Programmatic access via the agent surface.